Dario achieves goal of 100 business-to-business contracts in 2022

Northeast supermarket chain will deploy dario's cardiometabolic suite in 2023 new york , jan. 3, 2023 /prnewswire/ -- dariohealth corp. (nasdaq: drio) ("dario" or the "company"), a leader in the global digital therapeutics (dtx) market, announced today that a large northeast u.s. supermarket chain (the "employer") selected dario to help improve the cardiometabolic health of its employees beginning in the first quarter of 2023, marking the company reaching 100 enterprise contracts signed. this milestone achievement validates the company's strategic position as a leading provider of integrated digital chronic condition management solutions in the employer and payer markets.
DRIO Ratings Summary
DRIO Quant Ranking